Shasun Pharmaceuticals Ltd Merged Nine Monthly Results

Gross Sales

915.85

811.09

765.45

726.2

611.38

Excise Duty

0

0

0

0

11.03

Net Sales

915.85

811.09

765.45

726.2

600.34

Other Operating Income

42.83

38.34

42.99

34.68

21.92

Other Income

7.75

19.82

11.5

6.98

6.55

Total Income

966.43

869.26

819.94

767.86

628.82

Total Expenditure

889.66

788.79

715.51

695.63

590.39

PBIDT

76.77

80.45

104.43

72.23

38.43

Interest

39.63

27.75

26.19

24.95

22.93

PBDT

37.14

52.7

78.23

47.27

15.5

Depreciation

34.02

43.2

36.68

29.4

27.29

Minority Interest Before NP

0

0

0

0

0

Tax

0.02

-10.3

1.77

-23.71

0

Deferred Tax

0

0

0

0

0

Reported Profit After Tax

3.1

19.8

39.77

41.59

-11.78

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

1.6

19.8

39.77

41.59

-11.78

Extra-ordinary Items

0

0

0

0

2.73

Adjusted Profit After Extra-ordinary item

1.6

19.8

39.77

41.59

-14.51

EPS (Unit Curr.)

0.27

3.5

7.21

8.56

0

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

12.03

11.32

11.02

9.71

9.71

Public Shareholding (Number)

3,63,80,990

3,28,61,152

3,25,52,208

2,58,61,044

2,60,20,868

Public Shareholding (%)

60.51

58.02

59.04

53.27

53.61

Pledged/Encumbered - No. of Shares

29,18,296

75,38,000

16,50,000

73,48,600

51,08,600

Pledged/Encumbered - % in Total Promoters Holding

12.29

31.71

7.3

32.4

22.68

Pledged/Encumbered - % in Total Equity

4.85

13.31

2.99

15.14

10.52

Non Encumbered - No. of Shares

2,08,24,566

1,62,24,699

2,09,21,644

1,53,35,262

1,74,15,438

Non Encumbered - % in Total Promoters Holding

87.71

68.27

92.69

67.59

77.31

Non Encumbered - % in Total Equity

34.64

28.65

37.95

31.59

35.86

PBIDTM(%)

8.38

9.91

13.64

9.94

6.4

PBDTM(%)

4.05

6.49

10.22

6.51

2.58

PATM(%)

0.33

2.44

5.19

5.72

-1.96